Whipplewood Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Whipplewood Advisors's ALNY Position: Q2 2026 in Review
Whipplewood Advisors reduced its Alnylam Pharmaceuticals (ALNY) stake by 90% in Q2 2026, selling an estimated $7.84K and leaving 3 shares worth $903. The position accounts for ﹤0.01% of the portfolio, ranked #560.
Whipplewood Advisors first reported a position in ALNY in Q4 2024 and has held it in 5 quarters since. The position peaked at $13.7K in Q2 2025. 784 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Whipplewood Advisors held 3 shares of Alnylam Pharmaceuticals worth $903 as of Q2 2026.
- Whipplewood Advisors sold 26 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $7.84K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #560 holding.
- Whipplewood Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
- Whipplewood Advisors's Alnylam Pharmaceuticals position peaked at $13.7K in Q2 2025.
- 784 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.